Physician profile
David S Cochran
NPI 1467541433
$3,216.43
in general payments reported to CMS, 2019-2025
21 companies · $79.84 in 2025
The $79.84 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $582 · 2021: $342 · 2022: $696 · 2023: $352 · 2024: $395 · 2025: $79.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $519.64 | 2019-2025 | Impella |
| Philips North America LLC | $482.85 | 2020-2024 | (Br4) Coronary Undivided, (Cj8) Igt Devices Systems Undivided, (792) Multi Modality Ivus Other Systems |
| Shockwave Medical, INC | $346.85 | 2020-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $299.27 | 2019-2024 | Repatha |
| Abbott Laboratories | $227.17 | 2021-2024 | Amplatzer Amulet, I-Stat, Tacticath Ablation Catheter, Sensor Enabled |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $214.27 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $198.44 | 2019-2023 | Wolverine Coronary Cutting Balloon |
| Biotronik INC. | $183.15 | 2019 | |
| Medtronic Vascular, INC. | $125.35 | 2019-2020 | |
| Cardiovascular Systems INC. | $109.66 | 2019-2022 | |
| Medtronic, INC. | $103.88 | 2022-2024 | Corevalve Evolut R |
| Pfizer INC. | $73.98 | 2019-2020 | |
| Regeneron Pharmaceuticals, INC. | $72.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $62.89 | 2019-2022 | |
| Zoll Circulation INC | $62.48 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $39.74 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Penumbra, INC. | $32.71 | 2020-2021 | |
| Kestra Medical Technology Services, INC. | $19.42 | 2024 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $15.29 | 2024 | |
| Cardinal Health 200 LLC | $13.82 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cochran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.